Clinical efficacy and safety of imatinib treatment in children and adolescents with chronic myeloid leukemia: A single-center experience in China

Chronic myeloid leukemia (CML) is relatively rare in childhood and few studies have reported the clinical use of imatinib (IM) in pediatric CML. In this study, we evaluated the efficacy and tolerability of IM in children and adolescents with CML. We investigated 21 patients under 18 years of age wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Mengyue, Guan, Xianmin, Wen, Xianhao, Xiao, Jianwen, An, Xizhou, Yu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035079/
https://www.ncbi.nlm.nih.gov/pubmed/32049841
http://dx.doi.org/10.1097/MD.0000000000019150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035079/
https://www.ncbi.nlm.nih.gov/pubmed/32049841
http://dx.doi.org/10.1097/MD.0000000000019150

Ejemplares similares